Takenaka Partners — M&A Advisory Profile

01Advisory Approach

Sweet Spot

Japanese and Asian corporate acquirers seeking to access North American markets, technologies, and capabilities through strategic acquisitions in manufacturing, healthcare, food & beverage, and industrial sectors with TEV of $10M-$100M+.

Not A Fit If

Sellers requiring rapid processes, domestic-only advisory, PE-focused buyer networks, or transactions below $10M TEV where cross-border complexity is not present.

Unique cross-border expertise connecting North American targets with Japanese corporate acquirers. Deep relationships in Corporate Asia that most Western advisors lack. 37-year track record across multiple economic cycles. Institutional backing from YAMADA Consulting Group (TSE Prime listed).

02Process & Fees

Comprehensive cross-border transaction advisory: market research and target identification, buyer and seller introduction, deal structure optimization, regulatory navigation, transaction documentation, and execution support through close.

Fee Structure

Takenaka Partners Research

Advisory Approach

Takenaka Partners is a global cross-border M&A advisory and investment banking boutique founded in 1989, headquartered in Los Angeles with operations in Tokyo, Japan. The firm's core thesis is that successful cross-border M&A transactions require deep market knowledge, established relationships across Asia, and institutional-quality process management. They have built a proven track record of executing acquisitions where Japanese corporations acquire or invest in North American and international businesses. Their sweet spot is structuring transactions that allow Asian corporates to access new markets, technologies, and capabilities through acquisitive growth.

The firm specializes in providing tailored deal execution solutions that help clients exceed their strategic objectives. They maintain unparalleled access to key decision makers in Corporate Asia, which is their primary competitive advantage. In April 2024, Takenaka Partners was acquired by YAMADA Consulting Group (TSE Prime: 4792), further expanding their global reach and institutional resources.

Sector Focus

Takenaka Partners maintains active practices across manufacturing, healthcare, food & beverage, and industrial distribution sectors. Within manufacturing, they have particular expertise in industrial machinery, precision equipment, and manufacturing execution systems. Their healthcare practice focuses on medical devices, diagnostics, and consumer healthcare products. They also maintain active involvement in food processing, specialty chemicals, and industrial distribution, particularly in sectors where Japanese corporations seek strategic acquisitions in North America.

Their deal history shows clear strength in Japanese-to-US acquisitions. Recent transactions include Asahi Intecc USA acquiring Pathways Medical Corporation (medical device technology), Mentholatum Company acquiring Hydrox Laboratories (specialty healthcare products and disinfectants), Air Water America acquiring Noble Gas Solutions (industrial gas distribution), and Kameda Seika acquiring Mary's Gone Crackers (specialty food brand). This pattern demonstrates their expertise in connecting Japanese corporations with strategic acquisition targets across industrial and consumer sectors.

Deal Track Record

Takenaka Partners has facilitated 16 total deals according to third-party sources, comprising 14 M&A transactions and 2 funding rounds. This represents consistent activity over their 37-year history. Their most active period was 2020-2024, where they executed multiple significant cross-border transactions.

Key recent transactions include:

Asahi Intecc USA on Pathways Medical Corporation (April 2021) - Advised Asahi Intecc USA, a wholly-owned subsidiary of Asahi Intecc Co., Ltd. (a leading Japanese medical device company), on the acquisition of Pathways Medical Corporation. Pathways developed unique thin-film electrical conductor technology for medical guide wires with sensor capabilities. This transaction enabled Asahi to strengthen its development of guide wires and catheters with sensors, particularly their stroke smart guide wire program developed with SENSOME in France.

The Mentholatum Company on Hydrox Laboratories (November 2021) - Advised Mentholatum on acquiring Chicago-based Hydrox Laboratories, a 100-year-old leader in infection prevention and personal care products. Through this acquisition, Mentholatum expanded its product portfolio to include high-quality disinfectants, cleaners, and antiseptics, providing growth opportunities in the infection prevention and personal care markets.

Air Water America on Noble Gas Solutions (May 2022) - Advised Air Water America on the acquisition of Noble Gas Solutions, Inc., a leading independent gas and welding products distributor in New York. The transaction provided Noble Gas with additional resources to expand product offerings with Air Water's advanced gases and solutions technology.

Kameda Seika on Mary's Gone Crackers (2023) - Facilitated Kameda Seika's acquisition of majority stake in Mary's Gone Crackers, expanding Kameda's presence in specialty and organic crackers in the North American market.

Additional Transactions: Takenaka Partners has also advised on acquisitions including Merritt Plywood Machinery, Inc., Industrial Tool, Inc., Noritsu (Japanese electronics/imaging equipment), and Meinan Machinery Works. Combined, their transaction history demonstrates consistent execution across manufacturing equipment, healthcare/medical devices, and food & beverage sectors.

Process & Fee Structure

While Takenaka Partners does not publicly disclose their specific fee structure, their positioning as a boutique advisory firm suggests engagement around $1M-$3M+ for mid-market M&A transactions. As a non-FINRA registered advisory firm, they operate with flexibility in fee models, likely utilizing combinations of retainers and success-based fees. The firm emphasizes comprehensive research and greenfield target identification, which suggests value-based pricing models.

Their process includes: (1) comprehensive market research and target identification using their global network, (2) strategic buyer and seller identification across Asia and North America, (3) transaction advisory and deal structure optimization, and (4) execution support through close. Typical engagement timelines appear to be 6-12 months based on their deal velocity.

Buyer Network & Strategic Relationships

Takenaka Partners' primary buyer network consists of major Japanese corporations across manufacturing, chemicals, food, and healthcare sectors. Their relationship network includes:

Strategic Acquirers: Asahi Intecc (medical devices), Mentholatum Company (consumer healthcare), Kameda Seika (food & beverage), Air Water (industrial gases and solutions), YAMADA Consulting Group (consulting and operations).

Network Reach: Member of World Services Group, a global network of 130+ independent member firms across 115+ countries. This provides access to multinational corporations, private equity firms, and strategic buyers across multiple geographies.

Their competitive advantage lies in their unique ability to connect North American acquisition targets with Japanese corporate acquirers who seek entry into or expansion in North American markets. This cross-border specialization is increasingly valuable as Japanese corporations pursue aggressive international expansion strategies.

Competitive Positioning

Takenaka Partners differentiates itself through:

Cross-Border Expertise - Deep relationships and market knowledge in both Japan and North America, a capability few mid-market advisory firms possess
Institutional Relationships - Access to major Japanese corporation decision makers and board-level contacts that most Western advisory firms lack
Network Infrastructure - Member of World Services Group providing global reach and local market expertise
Greenfield Research Capabilities - Premium service for industry and market research, target identification, and screening
Proven Track Record - 37 years of consistent transaction execution across multiple economic cycles
Institutional Backing - Acquisition by YAMADA Consulting Group provides additional resources and capabilities

Not a Fit If

Takenaka Partners typically focuses on sellers willing to engage with Japanese corporate acquirers. The firm is not ideal if:

You require private equity buyers as the primary exit (they specialize in strategic acquisitions)
You need a rapid or limited process (comprehensive market research takes time)
Your business is not suitable for Japanese corporate integration
You require domestic-only advisory support
Your transaction is below $5-10M TEV (minimum engagement size likely 2x+ higher than typical LMM firms)

Team

Takenaka Partners operates with a lean team of approximately 37 professionals across Los Angeles and Tokyo offices. Key leadership includes:

Hidehito "Jake" Kanai - President and Chief Executive Officer. Joined Takenaka Partners in 2020 and assumed CEO role in April 2024. Previously spent three years as Partner at Singer Lewak in Assurance and Outsourcing Services, ten years in executive roles in Japan, and began his career as Partner in Assurance at KPMG LLP across Los Angeles and Mountain View.

Paul Yonamine - Chairman. Brings four decades of leadership in US-Japan business relations. Previously served as Executive Chairman and CEO of Central Pacific Financial Corp (NYSE: CPF) and Central Pacific Bank, and as Chairman Emeritus of both entities. Deep experience in cross-border transactions and strategic leadership.

Joseph Kim - Managing Director. Leads transaction advisory on major cross-border deals.

James Horiuchi - Managing Director. Senior transaction execution leadership.

Naoko Inoue, MBA - Senior transaction advisor with Japanese market expertise.

Christine Freitas, PMP®, CSM® - Project management and process optimization expertise.

Yuanyi Wu - Analyst/Associate supporting research and transaction work.

Saika Maeda - Team member supporting research and market analysis.

The team combines Japanese market knowledge with North American M&A expertise, enabling effective navigation of cross-border transactions.

Geographic Coverage

Primarily US-based operations in Los Angeles with deep connections throughout California. International capability through Tokyo office with strong relationships throughout Japan and Asia. Effectively covers North America (primary focus), Japan, and broader Asia-Pacific region through network relationships. Participating member of World Services Group providing access to markets across 115+ countries.

Institutional Changes (April 2024)

In April 2024, YAMADA Consulting Group Co., Ltd. (TSE Prime: 4792), a major Japanese consulting and operations firm, acquired Takenaka Partners. This acquisition consolidated Takenaka Partners and its subsidiary Takenaka Partners LLC as consolidated subsidiaries of YAMADA Consulting Group. This strategic move significantly expanded Takenaka Partners' resources, capabilities, and institutional backing while maintaining the specialized M&A advisory practice. The acquisition reinforces the firm's position as a leading cross-border M&A advisor for Japanese corporations entering or expanding in North American markets.